Anne-Emmanuelle Ambresin, MD
- 2Articles
- 8.4KReads1
- 2015–2019Active
- 17Collaborators
- 86Citations2
About
Anne-Emmanuelle Ambresin, MD, has published research focusing on metabolic side effects associated with psychiatric treatments, particularly lipid disturbances and weight changes in patients with schizophrenia and schizoaffective disorders. Her work includes studies on plasma lipid worsening and the prediction of long-term weight gain during psychotropic drug treatment. Ambresin has collaborated frequently with Aurélie Delacrétaz, Chin B. Eap, Frederik Vandenberghe, Mehdi Gholam-Rezaee, and Philippe Conus.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
